These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11751768)

  • 1. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.
    Reinert RR; Al-Lahham A; Lemperle M; Tenholte C; Briefs C; Haupts S; Gerards HH; Lütticken R
    J Antimicrob Chemother; 2002 Jan; 49(1):61-8. PubMed ID: 11751768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2015 Oct; 305(7):776-83. PubMed ID: 26324014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017.
    Kastrin T; Paragi M; Erčulj V; Žohar Čretnik T; ; Bajec T; Čižman M
    J Glob Antimicrob Resist; 2019 Mar; 16():242-248. PubMed ID: 30391398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N
    Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000.
    Reinert RR; Lütticken R; Reinert S; Al-Lahham A; Lemmen S
    Chemotherapy; 2004 Oct; 50(4):184-9. PubMed ID: 15347911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B; Köseoglu O; Gür D; Bryskier A
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008.
    Imöhl M; Reinert RR; Mutscher C; van der Linden M
    BMC Microbiol; 2010 Nov; 10():299. PubMed ID: 21108778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.
    Bruinsma N; Kristinsson KG; Bronzwaer S; Schrijnemakers P; Degener J; Tiemersma E; Hryniewicz W; Monen J; Grundmann H;
    J Antimicrob Chemother; 2004 Dec; 54(6):1045-50. PubMed ID: 15531598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal carriage of Streptococcus pneumoniae in Romanian children before the introduction of the pneumococcal conjugated vaccination into the national immunization programme: a national, multi-centre, cross-sectional observational study.
    Luminos M; Dorobat O; Jugulete G; Popescu GA; Florea D; Draganescu A; Cercel AS; Rafila A;
    Int J Infect Dis; 2014 Dec; 29():169-73. PubMed ID: 25461243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotypes and antibiotic resistance of non-invasive Streptococcus pneumoniae circulating in pediatric hospitals in Moscow, Russia.
    Mayanskiy N; Alyabieva N; Ponomarenko O; Lazareva A; Katosova L; Ivanenko A; Kulichenko T; Namazova-Baranova L; Baranov A
    Int J Infect Dis; 2014 Mar; 20():58-62. PubMed ID: 24462930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.
    Jenkins SG; Farrell DJ; Patel M; Lavin BS
    J Infect; 2005 Dec; 51(5):355-63. PubMed ID: 15950288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.
    Dias R; Caniça M
    Epidemiol Infect; 2008 Jul; 136(7):928-39. PubMed ID: 17697443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.
    Weiss K; Guilbault C; Cortes L; Restieri C; Low DE;
    J Antimicrob Chemother; 2002 Sep; 50(3):403-6. PubMed ID: 12205066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.